Prophylactic administration of diphenhydramine/paracetamol reduced emergence agitation and postoperative pain following maxillofacial surgeries: a randomized controlled trial

Eur Arch Otorhinolaryngol. 2022 Mar;279(3):1467-1471. doi: 10.1007/s00405-021-06904-4. Epub 2021 May 27.

Abstract

Background: Emergence agitation after maxillofacial surgeries is an anxious and problematic complication for the surgeon and anesthesiologist that may lead to self-extubation, haemorrhage, and surgical destruction. In this study, we investigated the effects of preemptive administration of diphenhydramine on emergence agitation and quality of recovery after maxillofacial surgery in adult patients.

Methods: Eighty-five patients undergoing maxillofacial surgery were randomized into two groups. The diphenhydramine group (Group D, n = 40) received diphenhydramine premedication 0.5 mg/kg before anesthesia induction, while the control group (Group C, n = 40) received volume-matched normal saline as a placebo. Before incision, all patients receive 0.1 mg/kg morphine sulfate slowly intravenously within 5 min. Continuous infusion of remifentanil 0.2 μg/kg/h and inhalation of isoflurane was maintained during the anesthesia period. Paracetamol 1 g was infused 15 min before extubation. We evaluated the incidence of agitation during the extubation period after general anesthesia, hemodynamic parameters, and recovery characteristics during the postoperative period.

Results: During extubation time, the incidence of emergence agitation was lower in Group D than in Group C (16% vs. 49%, P = 0.041). The time from isoflurane discontinuation to extubation (7.7 min in Group D vs. 6.8 min in Group C, P = 0.082) was not different. Grade of cough during emergence, the severity of pain, analgesic requirements, and hemodynamic changes were lower in group D compared with Group C.

Conclusions: Preemptive administration of diphenhydramine provided smooth emergence from anesthesia. It also improved the quality of recovery after maxillofacial surgery.

Trial registration number: This study was registered at http://irct.ir (registration number IRCT20130304012695N3).

Keywords: Acute pain; Diphenhydramine; Emergence agitation; General anesthesia; Maxillofacial surgery.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acetaminophen / therapeutic use
  • Adult
  • Anesthesia Recovery Period
  • Anesthesia, General / adverse effects
  • Dexmedetomidine*
  • Diphenhydramine / therapeutic use
  • Double-Blind Method
  • Emergence Delirium* / drug therapy
  • Emergence Delirium* / epidemiology
  • Emergence Delirium* / prevention & control
  • Humans
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / etiology
  • Pain, Postoperative / prevention & control

Substances

  • Acetaminophen
  • Dexmedetomidine
  • Diphenhydramine

Associated data

  • IRCT/IRCT20130304012695N3